SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-23-001290
Filing Date
2023-07-11
Accepted
2023-07-11 16:05:15
Documents
12
Period of Report
2023-07-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e4860_8k.htm   iXBRL 8-K 29940
  Complete submission text file 0001731122-23-001290.txt   203201

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE enob-20230707.xsd EX-101.SCH 3024
3 XBRL LABEL FILE enob-20230707_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE enob-20230707_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT e4860_8k_htm.xml XML 3327
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 231082211
SIC: 2834 Pharmaceutical Preparations